Yijing Capital
Overview
Yijing Capital is a venture capital firm that invests in companies with high growth potential, focusing on advanced technology, life sciences, and new consumption and services sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Biren Technology | Mar 2021 | Series B | Co-investor |
| IGEN Tech | Jan 2023 | Series C Extension | Co-investor |
| Origincell Technology Group | Jan 2021 | Series A | Lead |
| eTheRNA | Jun 2020 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Yijing Capital based?
Yijing Capital is headquartered in Shanghai, China.
When was Yijing Capital founded?
Yijing Capital was founded in 2015.
How many portfolio companies does Yijing Capital have?
Yijing Capital has 4 portfolio companies in Caplight's dataset.
What are some companies in Yijing Capital's portfolio?
Portfolio companies visible on Caplight include Biren Technology, IGEN Tech, Origincell Technology Group, eTheRNA.
What was Yijing Capital's most recent investment shown here?
Yijing Capital's most recent investment in this portfolio sample was in IGEN Tech in 2023.
What sectors does Yijing Capital focus on?
Yijing Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Energy & Sustainability, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Yijing Capital focus on?
Yijing Capital typically invests at the Mid stage.
What is Yijing Capital's AUM?
Yijing Capital's assets under management are estimated between $1.4B and $1.4B.